BABY Rabbit COMPLEMENT Serum & Cells
Referência OOSA10423
Tamanho : 1ml
Marca : Aviva Systems Biology
Contactar o distribuidor local :
Telefone : +1 850 650 7790
| Datasheets/Manuals | Printable datasheet for BABY Rabbit COMPLEMENT Serum & Cells (OOSA10423) |
|---|
| Predicted Species Reactivity | Rabbit |
|---|---|
| Product Format | Lyophilized |
| Application | FC |
| Reconstitution and Storage | 2°C to 8°C|-80°C |
| Specificity | This rabbit serum is intended for use as a source of rabbit complement for cytotoxicity studies. |
| Reference | 1. Council of Europe. (1983) Essential aspects of tissue typing: Preparation, use, storage of reagents and standardisation of complement. European Health Committee, Strasbourg, ISBN 92-871.224-4. 2. Edited by J.G.Ray. (1979) NIAID Manual of tissue typing techniques . Publication No. NIH-80-545. 3. Anderson. L.D. Jr, et al. (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogenic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res. 59: 1525-1530. 4. Mason. J. et al. (2002) Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ.Res. 91: 969-703. 5. Lidington. E. et al. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement mediated injury. Blood. 96: 2784-2972. 6. De Clerq. L. et al. (1997) An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue. J.Anim. Sci. 75: 1791-1797. |
|---|---|
| Description of Target | BABY RABBIT COMPLEMENT |